Nanobiotix (NANO) Stock Statistics & Valuation Metrics

Nanobiotix has a market cap or net worth of €1.57B. The enterprise value is €1.60B.

Nanobiotix has 50,619,583 shares outstanding. The number of shares has decreased by -2.65% in one year.

Nanobiotix’s return on equity (ROE) is 0.28 and return on invested capital (ROIC) is -74.29%.

The current PE Ratio of Nanobiotix is ―. Nanobiotix’s PEG ratio is 0.59.

In the last 12 months, Nanobiotix had revenue of 29.64M and earned -23.96M in profits. Earnings per share was -0.51.

In the last 12 months, operating cash flow was -33.42M and capital expenditures -546.00K, giving a free cash flow of -33.97M billion.

Nanobiotix pays an annual dividend of ―, resulting in a dividend yield of ―

Nanobiotix upcoming earnings date is Sep 30, 2026, TBA (Confirmed).

Nanobiotix as a current ratio of 1.09, with Debt / Equity ratio of -112.83%

In the past 12 months, Nanobiotix has paid 3.00K in taxes.

Nanobiotix EV to EBITDA ratio is -80.15, with an EV/FCF ratio of -28.47.

Nanobiotix has €52.75M in cash and marketable securities with €95.32M in debt, giving a net cash position of -€42.57M billion.

Gross margin is 100.00%, with operating margin of -36.49%, and net profit margin of -80.83%.

The average price target for Nanobiotix is €55.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy